BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 22 filers reported holding BETTER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $182,962 | -61.4% | 499,897 | +14.0% | 0.00% | – |
| Q2 2023 | $473,557 | +54.3% | 438,479 | 0.0% | 0.00% | – |
| Q1 2023 | $306,935 | -36.1% | 438,479 | +0.9% | 0.00% | – |
| Q4 2022 | $480,431 | -37.2% | 434,779 | +0.0% | 0.00% | – |
| Q3 2022 | $765,000 | +47.1% | 434,644 | +30.3% | 0.00% | – |
| Q2 2022 | $520,000 | -7.6% | 333,546 | +17.3% | 0.00% | – |
| Q1 2022 | $563,000 | -40.5% | 284,395 | +39.6% | 0.00% | – |
| Q4 2021 | $947,000 | – | 203,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTORAL ASSET MANAGEMENT INC | 973,833 | $4,528,000 | 0.68% |
| Monashee Investment Management LLC | 217,900 | $1,013,000 | 0.25% |
| Blue Water Life Science Advisors, LP | 100,000 | $465,000 | 0.14% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,350,000 | $6,278,000 | 0.03% |
| Alyeska Investment Group, L.P. | 344,170 | $1,600,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 58,100 | $270,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 124,749 | $580,000 | 0.00% |
| UBS Group AG | 2,969 | $14,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 59 | $0 | 0.00% |
| NORTHERN TRUST CORP | 16,703 | $78,000 | 0.00% |